Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors von Donnelly‐Roberts, Diana L, Namovic, Marian T, Han, Ping, Jarvis, Michael F

Volltext

Decatastrophizing research irreproducibility von Jarvis, Michael F.

Volltext

A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat von Jarvis, Michael F, Honore, Prisca, Shieh, Char-Chang, Chapman, Mark, Joshi, Shailen, Zhang, Xu-Feng, Kort, Michael, Carroll, William, Marron, Brian, Atkinson, Robert, Thomas, James, Liu, Dong, Krambis, Michael, Liu, Yi, McGaraughty, Steve, Chu, Katharine, Roeloffs, Rosemarie, Zhong, Chengmin, Mikusa, Joseph P, Hernandez, Gricelda, Gauvin, Donna, Wade, Carrie, Zhu, Chang, Pai, Madhavi, Scanio, Marc, Shi, Lei, Drizin, Irene, Gregg, Robert, Matulenko, Mark, Hakeem, Ahmed, Gross, Michael, Johnson, Matthew, Marsh, Kennan, Wagoner, P. Kay, Sullivan, James P, Faltynek, Connie R, Krafte, Douglas S

Volltext

Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders von BASSO, Ana M, BRATCHER, Natalie A, HARRIS, Richard R, JARVIS, Michael F, DECKER, Michael W, RUETER, Lynne E

Volltext

Biochemical and pharmacological assessment of MAP-kinase signaling along pain pathways in experimental rodent models: a potential tool for the discovery of novel antinociceptive th... von Edelmayer, Rebecca M., Brederson, Jill-Desiree, Jarvis, Michael F., Bitner, Robert S.

Volltext

Adenosine kinase: A key regulator of purinergic physiology von Boison, Detlev, Jarvis, Michael F.

Volltext

Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps von Jarvis, Michael F, Williams, Michael

Volltext

The neural–glial purinergic receptor ensemble in chronic pain states von Jarvis, Michael F

Volltext

P2X receptors as drug targets von North, R Alan, Jarvis, Michael F

Volltext

Characterization and comparison of rat monosodium iodoacetate and medial meniscal tear models of osteoarthritic pain von Brederson, Jill‐Desiree, Chu, Katharine L., Xu, Jun, Nikkel, Arthur L., Markosyan, Stella, Jarvis, Michael F., Edelmayer, Rebecca, Bitner, Robert S., McGaraughty, Steve

Volltext

Pharmacology Research & Perspectives: A Decade of Progress von Jarvis, Michael F., Davies, Emily, Martin, Jennifer H.

Volltext

Andrew Lawrence, Editor‐in‐Chief 2018–2020 von Jarvis, Michael F., Martin, Jennifer

Volltext

Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 von Illes, Peter, Müller, Christa E., Jacobson, Kenneth A., Grutter, Thomas, Nicke, Annette, Fountain, Samuel J., Kennedy, Charles, Schmalzing, Günther, Jarvis, Michael F., Stojilkovic, Stanko S., King, Brian F., Di Virgilio, Francesco

Volltext

P2X receptor antagonists for pain management: examination of binding and physicochemical properties von Gum, Rebecca J., Wakefield, Brian, Jarvis, Michael F.

Volltext

Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice von Hansen, Rikke Rie, Nasser, Arafat, Falk, Sarah, Baldvinsson, Signe B., Ohlsson, Pernille H., Bahl, Justyna M.C., Jarvis, Michael F., Ding, Ming, Heegaard, Anne-Marie

Volltext

A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat von Jarvis, Michael F, Burgard, Edward C, McGaraughty, Steve, Honore, Prisca, Lynch, Kevin, Brennan, Timothy J, Subieta, Alberto, Van Biesen, Tim, Cartmell, Jayne, Bianchi, Bruce, Niforatos, Wende, Kage, Karen, Yu, Haixia, Mikusa, Joe, Wismer, Carol T, Zhu, Chang Z, Chu, Katharine, Lee, Chih-Hung, Stewart, Andrew O, Polakowski, James, Cox, Bryan F, Kowaluk, Elizabeth, Williams, Michael, Sullivan, James, Faltynek, Connie

Volltext

Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia von Honore, Prisca, Chandran, Prasant, Hernandez, Gricelda, Gauvin, Donna M., Mikusa, Joseph P., Zhong, Chengmin, Joshi, Shailen K., Ghilardi, Joseph R., Sevcik, Molly A., Fryer, Ryan M., Segreti, Jason A., Banfor, Patricia N., Marsh, Kennan, Neelands, Torben, Bayburt, Erol, Daanen, Jerome F., Gomtsyan, Arthur, Lee, Chih-Hung, Kort, Michael E., Reilly, Regina M., Surowy, Carol S., Kym, Philip R., Mantyh, Patrick W., Sullivan, James P., Jarvis, Michael F., Faltynek, Connie R.

Volltext

[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors von Donnelly-Roberts, Diana L., Namovic, Marian T., Surber, Bruce, Vaidyanathan, Srirajan X., Perez-Medrano, Arturo, Wang, Ying, Carroll, William A., Jarvis, Michael F.

Volltext

Geoffery Burnstock’s influence on the evolution of P2X3 receptor pharmacology von Jarvis, Michael F.

Volltext

New author guidelines and launch of Short Reports von Lawrence, Andrew J., Jarvis, Michael F.

Volltext